Objective Hepatocellular carcinoma (HCC) has become a pressing health problem facing
the world today due to its high morbidity, high mortality, and late discovery. As a diagnostic …

Hepatocellular carcinoma (HCC) represents the fifth most common cancer in the world, and
the third most frequent oncological cause of death. The incidence of HCC is on the increase …

Background As a promising biomarker of hepatocellular carcinoma (HCC), protein induced
by vitamin K absence or antagonist-II (PIVKA-II) has been studied extensively. However, its …

Aims Des‐gamma–carboxy prothrombin (DCP) and α‐fetoprotein (AFP) are useful tumor
markers for the detection of hepatocellular carcinoma (HCC). However, it remains …

Background Hepatocellular carcinoma (HCC) occurs mostly in people with chronic liver
disease and ranks sixth in terms of global instances of cancer, and fourth in terms of cancer …

Abstract Background and Aim The serpin squamous cell carcinoma antigen complexed with
IgM (SCCA‐IgM) has been reported as a promising serological marker for hepatocellular …

Detecting cancer biomarkers at an early stage at the clinical level has been the interest of
numerous researchers over the years due to its impact on recovery. Therefore, attention is …

It has been reported that Golgi protein-73 (GP73), glypican-3 (GPC3), and des-γ-carboxy
prothrombin (DCP) could serve as serum markers for the early detection of hepatocellular …

Background Protein induced by vitamin K absence or antagonist-II (PIVKA-II) and α-
fetoprotein (AFP) are promising tumor markers for the diagnosis of hepatocellular carcinoma …

Background: Human epididymis protein 4 (HE4), kallikrein 6 (KLK6), osteopontin (OPN) and
soluble mesothelin-related peptide (SMRP) are new promising biomarkers that could …